vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Eightco Holdings Inc. (ORBS). Click either name above to swap in a different company.
Eightco Holdings Inc. is the larger business by last-quarter revenue ($10.2M vs $8.1M, roughly 1.3× Arcellx, Inc.). Arcellx, Inc. runs the higher net margin — -766.0% vs -2281.6%, a 1515.6% gap on every dollar of revenue. On growth, Eightco Holdings Inc. posted the faster year-over-year revenue change (-49.9% vs -79.3%). Eightco Holdings Inc. produced more free cash flow last quarter ($-11.0M vs $-63.9M). Over the past eight quarters, Eightco Holdings Inc.'s revenue compounded faster (13.1% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
ACLX vs ORBS — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $10.2M |
| Net Profit | $-62.3M | $-232.5M |
| Gross Margin | — | -13.0% |
| Operating Margin | -847.6% | -475.0% |
| Net Margin | -766.0% | -2281.6% |
| Revenue YoY | -79.3% | -49.9% |
| Net Profit YoY | -765.1% | -9183.3% |
| EPS (diluted) | $-1.13 | $-2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $10.2M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | $8.1M | $9.9M | ||
| Q4 24 | $15.3M | $20.3M | ||
| Q3 24 | $26.0M | $6.1M | ||
| Q2 24 | $27.4M | $5.3M | ||
| Q1 24 | $39.3M | $8.0M |
| Q4 25 | — | $-232.5M | ||
| Q3 25 | — | $-25.8M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | $-62.3M | $-2.5M | ||
| Q4 24 | $-47.1M | $-2.5M | ||
| Q3 24 | $-25.9M | $-3.2M | ||
| Q2 24 | $-27.2M | $4.4M | ||
| Q1 24 | $-7.2M | $1.9M |
| Q4 25 | — | -13.0% | ||
| Q3 25 | — | -3.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 25.1% | ||
| Q1 24 | — | 17.5% |
| Q4 25 | — | -475.0% | ||
| Q3 25 | — | -116.9% | ||
| Q2 25 | — | -15.9% | ||
| Q1 25 | -847.6% | -14.3% | ||
| Q4 24 | -348.2% | -11.9% | ||
| Q3 24 | -129.1% | -29.1% | ||
| Q2 24 | -127.8% | -16.4% | ||
| Q1 24 | -40.3% | -39.6% |
| Q4 25 | — | -2281.6% | ||
| Q3 25 | — | -487.6% | ||
| Q2 25 | — | -15.4% | ||
| Q1 25 | -766.0% | -25.7% | ||
| Q4 24 | -308.4% | -12.3% | ||
| Q3 24 | -99.4% | -52.5% | ||
| Q2 24 | -99.3% | 84.2% | ||
| Q1 24 | -18.3% | 24.4% |
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.58 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | $-1.13 | $-0.84 | ||
| Q4 24 | $-0.87 | $-1.44 | ||
| Q3 24 | $-0.48 | $-1.77 | ||
| Q2 24 | $-0.51 | $2.15 | ||
| Q1 24 | $-0.14 | $1.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $58.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $232.6M |
| Total Assets | $648.1M | $250.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $58.5M | ||
| Q3 25 | — | $23.7M | ||
| Q2 25 | — | $696.3K | ||
| Q1 25 | $543.3M | $434.4K | ||
| Q4 24 | $587.4M | $239.2K | ||
| Q3 24 | $574.3M | $2.4M | ||
| Q2 24 | $516.7M | $363.1K | ||
| Q1 24 | $573.9M | $808.8K |
| Q4 25 | — | $232.6M | ||
| Q3 25 | — | $339.2M | ||
| Q2 25 | — | $8.9M | ||
| Q1 25 | $416.9M | $9.7M | ||
| Q4 24 | $454.8M | $11.9M | ||
| Q3 24 | $483.0M | $13.0M | ||
| Q2 24 | $487.2M | $13.8M | ||
| Q1 24 | $496.6M | $3.9M |
| Q4 25 | — | $250.2M | ||
| Q3 25 | — | $355.5M | ||
| Q2 25 | — | $48.7M | ||
| Q1 25 | $648.1M | $47.6M | ||
| Q4 24 | $711.3M | $50.8M | ||
| Q3 24 | $764.9M | $49.2M | ||
| Q2 24 | $734.3M | $48.4M | ||
| Q1 24 | $779.7M | $50.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $-11.0M |
| Free Cash FlowOCF − Capex | $-63.9M | $-11.0M |
| FCF MarginFCF / Revenue | -786.4% | -107.7% |
| Capex IntensityCapex / Revenue | 9.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-11.0M | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $-659.2K | ||
| Q1 25 | $-63.1M | $999.8K | ||
| Q4 24 | $-46.0M | $-6.6M | ||
| Q3 24 | $30.7M | $77.7K | ||
| Q2 24 | $-36.2M | $-440.3K | ||
| Q1 24 | $-31.9M | $-723.3K |
| Q4 25 | — | $-11.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-661.3K | ||
| Q1 25 | $-63.9M | $999.7K | ||
| Q4 24 | $-47.5M | $-6.6M | ||
| Q3 24 | $28.4M | $73.0K | ||
| Q2 24 | $-39.5M | — | ||
| Q1 24 | $-38.3M | — |
| Q4 25 | — | -107.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -8.7% | ||
| Q1 25 | -786.4% | 10.1% | ||
| Q4 24 | -311.3% | -32.7% | ||
| Q3 24 | 109.2% | 1.2% | ||
| Q2 24 | -144.1% | — | ||
| Q1 24 | -97.7% | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 9.6% | 0.0% | ||
| Q4 24 | 9.8% | 0.0% | ||
| Q3 24 | 8.8% | 0.1% | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 16.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.10× | ||
| Q1 24 | — | -0.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
